Literature DB >> 3108322

Metabolism of platelet-activating factor in isolated perfused rat lung.

P E Haroldsen, N F Voelkel, J E Henson, P M Henson, R C Murphy.   

Abstract

The administration of platelet-activating factor (PAF) into the airway system of the lung is known to cause profound effects, yet little is known about the metabolism of this active lipid mediator. 3H-Labeled PAF administered into the airway of isolated rat lungs was rapidly and extensively metabolized. The tissue retained 96% of the administered radiolabel while the perfusate contained 4%. Characterization of the tissue retained lipid indicated metabolism into lyso-PAF (3.3%), phosphatidylcholine (82.3%), neutral lipid (1.7%) and intact PAF (10.2%). Analysis of tissue phosphatidylcholine by mass spectrometric techniques revealed metabolism of PAF to 1-0-hexadecyl-2-arachidonoyl-GPC, which represented 20-23% of the administered radiolabeled hexadecyl-PAF. These findings support the hypothesis that a relationship between PAF and arachidonate metabolism exists at the intact organ level. Autoradiographic analysis of the cellular distribution of the radiolabeled PAF metabolites in the lung tissue indicated labeling of two cell types, the alveolar type II cell and the nonciliated bronchiolar epithelial cell (Clara cell).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108322      PMCID: PMC424530          DOI: 10.1172/JCI113028

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Lung surfactant.

Authors:  J Goerke
Journal:  Biochim Biophys Acta       Date:  1974-12-16

Review 2.  Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds.

Authors:  R A Lewis; K F Austen
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

3.  The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin.

Authors:  M J Peck; P J Piper; T J Williams
Journal:  Prostaglandins       Date:  1981-02

4.  Leukotrienes and slow reacting substance of anaphylaxis (SRS-A).

Authors:  B Samuelsson; S Hammarström; R C Murphy; P Borgeat
Journal:  Allergy       Date:  1980-07       Impact factor: 13.146

5.  Nonimmunological production of leukotrienes induced by platelet-activating factor.

Authors:  N F Voelkel; S Worthen; J T Reeves; P M Henson; R C Murphy
Journal:  Science       Date:  1982-10-15       Impact factor: 47.728

6.  [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].

Authors:  J Benveniste; M Tencé; P Varenne; J Bidault; C Boullet; J Polonsky
Journal:  C R Seances Acad Sci D       Date:  1979-11-26

7.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

8.  Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1981-10

9.  Release of vasodilator prostaglandin, PGI2, from isolated rat lung during vasoconstriction.

Authors:  N F Voelkel; J G Gerber; I F McMurtry; A S Nies; J T Reeves
Journal:  Circ Res       Date:  1981-02       Impact factor: 17.367

10.  In vivo metabolism of a new class of biologically active phospholipids: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a platelet activating-hypotensive phospholipid.

Authors:  M L Blank; E A Cress; T Whittle; F Snyder
Journal:  Life Sci       Date:  1981-08-24       Impact factor: 5.037

View more
  9 in total

Review 1.  PAF antagonists. Their potential therapeutic role in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

2.  Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

Authors:  L Churchill; F H Chilton; D Proud
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.

Authors:  J R Fletcher; A G DiSimone; M A Earnest
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

4.  Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat.

Authors:  J S Warren
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

5.  Localization of [D-Ala2]deltorphin I-like immunoreactivity in perinatal rat respiratory system.

Authors:  S Matsui; M Fujimiya; J Matsui; Y Amakata; T Renda; H Kimura; T Maeda
Journal:  Histochem J       Date:  1994-08

Review 6.  Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid.

Authors:  F H Chilton; M Cluzel; M Triggiani
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.

Authors:  L Kahhak; A Roche; C Dubray; C Arnoux; J Benveniste
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

8.  Molecular species analysis of arachidonate containing glycerophosphocholines by tandem mass spectrometry.

Authors:  K Kayganich; R C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  1991-01       Impact factor: 3.109

9.  BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis.

Authors:  J L Pérez-Arellano; T Martín; J M López-Novoa; M L Sánchez; A Montero; A Jiménez
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.